Trial Profile
A Study Assessing Safety of Rituximab Biosimilar (Novex) in the Routine use Treatment in Argentina
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 12 Aug 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.